Filing Details
- Accession Number:
- 0002001011-24-000087
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-24 19:41:15
- Reporting Period:
- 2024-09-20
- Accepted Time:
- 2024-09-24 19:41:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 886163 | Ligand Pharmaceuticals Inc | LGND | Pharmaceutical Preparations (2834) | 770160744 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1649903 | E Matthew Korenberg | 555 Heritage Drive Suite 200 Jupiter FL 33458 | President & Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-09-20 | 4,982 | $49.99 | 57,052 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-09-20 | 6,275 | $104.10 | 50,777 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-09-23 | 395 | $49.99 | 51,172 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-09-23 | 9,377 | $52.84 | 60,549 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-09-23 | 2,481 | $100.05 | 58,068 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-09-23 | 7,090 | $101.61 | 50,978 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-09-23 | 201 | $102.05 | 50,777 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2024-09-20 | 4,982 | $0.00 | 4,982 | $49.99 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2024-09-23 | 395 | $0.00 | 395 | $49.99 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2024-09-23 | 9,377 | $0.00 | 9,377 | $52.84 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 395 | 2026-02-11 | No | 4 | M | Direct | |
| 0 | 2026-02-11 | No | 4 | M | Direct | |
| 42,436 | 2032-05-05 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $104.0000 to $104.4300. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $100.0000 to $100.2750. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $101.0450 to $102.0400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $102.0450 to $102.0950. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- This Option was previously reported as a Grant of 18,464 shares on February 11, 2016, which vested in full on February 11, 2020, at an exercise price of $85.79 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer.
- This Option was previously reported as a Grant of 30,189 shares on May 5, 2022, at an exercise price of $90.68 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer and shall be fully vested on February 5, 2026.
Billionaire Hedge Funds
